Company profile: Meda Pharma
1.1 - Company Overview
Company description
- Provider of pharmaceutical products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Meda Pharma
FibroBiologics
HQ: United States
Website
- Description: Provider of fibroblast cell-based regenerative therapies for chronic diseases, including multiple sclerosis (immune modulation and tissue regeneration), CybroCell universal donor cellular product for degenerative disc disease (disc regeneration and inflammation reduction), wound healing, and therapies to improve and extend the productive life of the thymus and enhance spleen function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FibroBiologics company profile →
Kinarus
HQ: Switzerland
Website
- Description: Provider of biopharmaceutical therapies targeting stress-related inflammatory processes. Develops KIN001, a pamapimod/pioglitazone combination with anti-inflammatory, anti-fibrotic, and antiviral activities, in Phase 2 trials for hospitalized COVID-19 (acute and long-term), wet AMD (reducing anti-VEGF injection frequency), and IPF (reducing lung fibrosis).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kinarus company profile →
Abbott
HQ: United States
Website
- Description: Provider of pharmaceuticals and healthcare products, including the FreeStyle Libre continuous glucose monitoring system for diabetes management, the MUAC z-score tape for assessing child nutritional status, and COVID-19 antibody testing to detect past infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abbott company profile →
Omeros
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical therapies for inflammation and central nervous system disorders, including MASP-2 antibodies (narsoplimab, OMS1029) for lectin pathway diseases such as TA-TMA and lupus nephritis; MASP-3 antibody (OMS906) for PNH; small-molecule PDE7 (OMS527) and PPARγ (OMS405) candidates for addiction; and GPR174 inhibitors for cancer immunotherapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omeros company profile →
Cumberland Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical offerings focused on acquiring, developing, and commercializing branded prescription products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cumberland Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Meda Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Meda Pharma
2.2 - Growth funds investing in similar companies to Meda Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Meda Pharma
4.2 - Public trading comparable groups for Meda Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →